Related Experiment Videos
Plasma C-reactive protein in haemodialysis
V Panichi1, M Migliori, S De Pietro
1Department of Internal Medicine, University of Pisa, Italy. v.panichi@int.med.unipi.it
Blood Purification
|August 18, 1999
Summary
Acute phase reactants like C-reactive protein (CRP) are active in inflammation. In hemodialysis patients, CRP may indicate long-term complications linked to contaminated dialysate and back-filtration.
Area of Science:
- Biochemistry
- Immunology
- Nephrology
Background:
- Acute phase reactants, such as C-reactive protein (CRP), are increasingly recognized not just as inflammation markers but also as active participants in the inflammatory response.
- Interleukin-6 (IL-6) is identified as a primary cytokine mediating CRP induction.
- Baseline CRP levels in healthy men predict future myocardial infarction and ischemic stroke, highlighting its systemic relevance.
Purpose of the Study:
- To investigate the role and implications of acute phase reactants, particularly CRP, in the morbidity and mortality of hemodialysis patients.
- To explore the potential link between contaminated dialysate, back-filtration, and chronic inflammation in hemodialysis.
Main Methods:
- Review of existing studies implicating CRP in malnutrition, EPO resistance, cardiovascular risk, and chronic stimulation in hemodialysis.
- Hypothesis generation based on the potential for contaminated dialysate exposure to induce long-term complications.
Main Results:
- Previous studies suggest CRP is associated with several adverse outcomes in hemodialysis patients.
- A hypothesis is proposed linking contaminated dialysate and back-filtration to a chronic inflammatory state.
Conclusions:
- The precise role of acute phase reactants in hemodialysis patient outcomes requires further elucidation.
- Avoiding back-filtration of contaminated dialysate may mitigate chronic inflammation and associated long-term complications in hemodialysis patients.